Risks of STIs among individuals using PrEP: An integrative review
View File(s)
Author Information
- Author(s)
- Details
-
Joseph J. Brennan, BSN, College of Nursing and Public Health, Adelphi University, Garden City, New York, USA
- Sigma Affiliation
- Non-member
Item Information
Item Link - Use this link for citations and online mentions.
Abstract
Pre-exposure prophylaxis (PrEP) medication is used to reduce acquiring HIV. PrEP does not protect against sexually transmitted infections. A literature review was performed, and it was found that in individuals on PrEP, there is reduced condom use, increasing STIs. Education and STI testing need to be performed at each visit.
Repository Posting Date
2020-09-16T21:15:39Z
Notes
Items submitted to a conference/event were evaluated/peer-reviewed at the time of abstract submission to the event. No other peer-review was provided prior to submission to the Sigma Repository, unless otherwise noted.
Type Information
| Type | Poster |
| Acquisition | Proxy-submission |
| Review Type | Abstract Review Only: Reviewed by Event Host |
| Format | Text-based Document |
Category Information
| Evidence Level | N/A |
| Research Approach | N/A |
| Keywords | Preexposure Prophylaxis (PrEP); Sexually Transmitted Diseases (STD); Sexually Transmitted Infection (STI) |
Conference Information
| Name | 31st International Nursing Research Congress |
| Host | Sigma Theta Tau International |
| Location | Virtual Event |
| Date | 2020 |
| Date | 2020 |
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Related items
Showing items related by title, author, creator and subjects.
-
Should pre-exposure prophylaxis (PrEP) services be blamed for the increased rate of sexual transmitted infections?
Pre-exposure prophylaxis (PrEP) is a lifesaving HIV prevention medication. Critics have shared their concerns for oral PrEP as it may be promoting unprotected sex among PrEP users, and indirectly may cause a new surge of ... -
Implementation interventions for pre-exposure prophylaxis (PrEP) in public health sexually transmitted infections clinic and related PrEP minority trends
Pre-exposure prophylaxis (PrEP) effectively reduces the risk of Human Immunodeficiency Virus (HIV) infection. PrEP implementation in public health clinics is suggested for increasing PrEP access; However, it is unclear if ... -
Pre-exposure prophylaxis (PrEP) for HIV prevention: A clinical practice review
(2016-03-21)Session presented on Saturday, November 7, 2015 and Sunday, November 8, 2015: Background: Primary care providers should possess current, evidenced-based knowledge in order to provide competent and compassionate patient ... -
Determining knowledge, attitudes, and beliefs about pre-exposure prophylaxis (PrEP) among transgender men
(2017-06-12)Purpose: The United States has witnessed a real shift in HIV prevention practices over the past several years. The prevention techniques that had been employed since the beginning of the epidemic have focused on behavior ... -
PrEP initiation in the primary care setting: An integrative review
Guideline-driven initiation of pre-exposure prophylaxis (PrEP) is a safe and effective strategy for reducing the incidence of human immunodeficiency virus (HIV). Yet, PrEP initiation is generally inadequate allowing for a ...
